Simpler Grants.gov #RFA-HL-26-003

NHLBI Emerging Investigator Award (EIA) for Heart, Lung, Blood, and Sleep Research

The National Institutes of Health (NIH), through the National Heart, Lung, and Blood Institute (NHLBI), is announcing the Emerging Investigator Award (EIA) to advance research in heart, lung, blood, and sleep (HLBS) fields. - Government Buyer: - National Institutes of Health (NIH) - National Heart, Lung, and Blood Institute (NHLBI) - Purpose and Scope: - Soliciting applications for the Emerging Investigator Award (EIA) under RFA-HL-26-003 - Supports experienced Program Directors/Principal Investigators (PDs/PIs) with at least two active NHLBI R01-equivalent awards - Designed to fund a comprehensive research program, not just a single project - Provides up to seven years of support for innovative, high-risk, and long-term research - Eligibility: - Open to government entities, businesses, nonprofits, and educational institutions - Products/Services Requested: - No specific OEMs, vendors, products, or purchase quantities are mentioned - This is a research grant opportunity, not a procurement of goods or services - Unique Requirements: - Focus on supporting established investigators with a strong track record in HLBS research - Emphasis on flexibility and long-term programmatic research within the NHLBI mission

Description

The NHLBI Emerging Investigator Award (EIA) aims to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors/Principal Investigators (PDs/PIs) with at least two NHLBI R01-equivalent awards. The award supports a research program within the scope of heart, lung, blood, and sleep (HLBS) research for up to seven years, allowing investigators to pursue high-risk, long-term research. The EIA is intended as the primary and likely sole source of NHLBI funding for the research program. Eligible applicants include a wide range of government, business, nonprofit, and educational entities.

View original listing